Renishaw plc (LON:RSW) Given Average Recommendation of “Hold” by Brokerages
Renishaw plc (LON:RSW) has received an average rating of “Hold” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is GBX 3,220.60 ($41.94).
A number of analysts have weighed in on RSW shares. Numis Securities Ltd cut Renishaw plc to a “hold” rating and set a GBX 3,700 ($48.18) price target for the company. in a research report on Wednesday, May 10th. Deutsche Bank AG reaffirmed a “sell” rating and issued a GBX 3,180 ($41.41) price target on shares of Renishaw plc in a research report on Monday. Finally, Barclays PLC reaffirmed an “underweight” rating on shares of Renishaw plc in a research report on Tuesday, April 25th.
Shares of Renishaw plc (LON:RSW) traded up 2.67% during midday trading on Monday, reaching GBX 4418.00. The company’s stock had a trading volume of 61,996 shares. The stock’s 50-day moving average is GBX 3,871.05 and its 200 day moving average is GBX 3,405.43. Renishaw plc has a 12 month low of GBX 2,340.48 and a 12 month high of GBX 4,434.00. The stock’s market capitalization is GBX 3.22 billion.
The firm also recently disclosed a dividend, which will be paid on Wednesday, October 25th. Investors of record on Thursday, September 21st will be given a dividend of GBX 39.50 ($0.51) per share. This represents a dividend yield of 0.95%. The ex-dividend date is Thursday, September 21st. This is a boost from Renishaw plc’s previous dividend of $12.50.
About Renishaw plc
Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.
Receive News & Ratings for Renishaw plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw plc and related companies with MarketBeat.com's FREE daily email newsletter.